Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …

Abstract Background Plasma ceramides (Cer), a subset of bioactive lipids, have mechanistic
links to atherosclerotic coronary artery disease (CAD) pathogenesis and are related to major …

Metabolic Syndrome (MS) is a rapidly growing medical problem worldwide and is
characterized by a cluster of age-related metabolic risk factors. The presence of MS …

Background Coronary artery stenosis induces heart diseases including acute coronary
syndrome (ACS). Some studies reported the ceramide species are associated with the ACS …

Background and aims The relationship between ceramides and the risk of mortality among
patients with coronary artery disease (CAD) is currently relatively sparse. This prospective …

Aim Emerging evidence suggests that specific plasma ceramides are involved in the
pathophysiology of cardiovascular disease (CVD) and other inflammation-associated …

Abstract Background Plasma ceramides (Cer) have been used to evaluate risk of
cardiovascular (CV) events in patients with coronary heart disease. We investigated the …

Background Recent cohort studies evaluated the association between some previously
identified high-risk ceramides [Cer (d18: 1/16: 0), Cer (d18: 1/18: 0), Cer (d18: 1/22: 0), Cer …

Background: Ceramides, biologically active lipids correlated to oxidative stress and
inflammation, have been associated with adverse outcomes in acute myocardial infarction …

Objective—Ceramides are sphingolipids involved with cellular signaling. Synthesis of
ceramides occurs in all tissues. Ceramides accumulate within tissues and the blood plasma …